Daniel P. Healy

2.3k total citations
62 papers, 1.7k citations indexed

About

Daniel P. Healy is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Daniel P. Healy has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 28 papers in Epidemiology and 17 papers in Infectious Diseases. Recurrent topics in Daniel P. Healy's work include Antibiotics Pharmacokinetics and Efficacy (29 papers), Antibiotic Resistance in Bacteria (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). Daniel P. Healy is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (29 papers), Antibiotic Resistance in Bacteria (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). Daniel P. Healy collaborates with scholars based in United States, South Korea and United Kingdom. Daniel P. Healy's co-authors include Ron E. Polk, Jan Sahai, G A FitzGerald, Francesca Catella, John A. Lawson, David T. Rock, Michael Kays, Eun Kyoung Chung, S. Christian Cheatham and Thomas J. Comstock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PEDIATRICS and The Journal of Infectious Diseases.

In The Last Decade

Daniel P. Healy

59 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel P. Healy United States 23 873 451 361 219 184 62 1.7k
Hans Georg Eichler Austria 26 700 0.8× 321 0.7× 117 0.3× 168 0.8× 214 1.2× 52 1.9k
Hendrik Bracht Germany 21 677 0.8× 697 1.5× 226 0.6× 231 1.1× 371 2.0× 75 1.9k
Reinier M. van Hest Netherlands 24 469 0.5× 405 0.9× 249 0.7× 152 0.7× 171 0.9× 83 1.9k
William Salzer United States 14 323 0.4× 300 0.7× 257 0.7× 121 0.6× 348 1.9× 26 2.1k
Robert E. Ariano Canada 25 799 0.9× 553 1.2× 260 0.7× 359 1.6× 362 2.0× 74 1.9k
Martina Kinzig Germany 31 1.2k 1.4× 732 1.6× 353 1.0× 561 2.6× 385 2.1× 104 2.9k
I. Nilsson-Ehle Sweden 24 865 1.0× 357 0.8× 216 0.6× 318 1.5× 155 0.8× 58 1.8k
Thaddeus H. Grasela United States 31 905 1.0× 529 1.2× 363 1.0× 413 1.9× 249 1.4× 100 2.6k
Olivier Petitjean France 22 667 0.8× 450 1.0× 246 0.7× 330 1.5× 75 0.4× 89 1.6k
Frédéric Cotton Belgium 28 815 0.9× 529 1.2× 282 0.8× 282 1.3× 164 0.9× 120 2.3k

Countries citing papers authored by Daniel P. Healy

Since Specialization
Citations

This map shows the geographic impact of Daniel P. Healy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Healy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Healy more than expected).

Fields of papers citing papers by Daniel P. Healy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Healy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Healy. The network helps show where Daniel P. Healy may publish in the future.

Co-authorship network of co-authors of Daniel P. Healy

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Healy. A scholar is included among the top collaborators of Daniel P. Healy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Healy. Daniel P. Healy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rice, Teresa C., Joshua W. Kuethe, Emily F. Midura, et al.. (2016). Burn injury influences the T cell homeostasis in a butyrate-acid sphingomyelinase dependent manner. Cellular Immunology. 313. 25–31. 13 indexed citations
3.
Kuethe, Joshua W., Emily F. Midura, Teresa C. Rice, et al.. (2015). Fecal Microbiota Transplant Restores Mucosal Integrity in a Murine Model of Burn Injury. Shock. 45(6). 647–652. 37 indexed citations
4.
Stockmann, Chris, Michele M. Gottschlich, Daniel P. Healy, et al.. (2014). Relationship Between Zolpidem Concentrations and Sleep Parameters in Pediatric Burn Patients. Journal of Burn Care & Research. 36(1). 137–144. 6 indexed citations
5.
Healy, Daniel P., et al.. (2014). Trends in Bacterial Wound Isolates and Antimicrobial Susceptibility in a Pediatric Burn Hospital. Journal of Burn Care & Research. 35(5). e304–e311. 16 indexed citations
6.
Tian, Yu, Chris Stockmann, Daniel P. Healy, et al.. (2014). Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis. Journal of Burn Care & Research. 36(4). e244–e252. 23 indexed citations
7.
Cheatham, S. Christian, et al.. (2013). Steady‐state pharmacokinetics and pharmacodynamics of meropenem in morbidly obese patients hospitalized in an intensive care unit. The Journal of Clinical Pharmacology. 54(3). 324–330. 29 indexed citations
8.
Sherwin, Catherine M.T., Chris Stockmann, Daniel P. Healy, et al.. (2013). Amikacin population pharmacokinetics among paediatric burn patients. Burns. 40(2). 311–318. 22 indexed citations
9.
Cheatham, S. Christian, Katherine M. Shea, Daniel P. Healy, et al.. (2010). Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients. International Journal of Antimicrobial Agents. 37(1). 46–50. 22 indexed citations
10.
Healy, Daniel P., et al.. (2010). Pharmacokinetics of Colistin in an Adolescent Boy With Extensive Burn Injury. Journal of Burn Care & Research. 32(1). e7–e11. 10 indexed citations
11.
Healy, Daniel P.. (2007). Macrolide immunomodulation of chronic respiratory diseases. Current Infectious Disease Reports. 9(1). 7–13. 40 indexed citations
12.
Chen, Yan, Jeff J. Guo, Daniel P. Healy, & Siyan Zhan. (2007). Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysis. Pharmacy Practice. 5(1). 1–9. 23 indexed citations
13.
Healy, Daniel P., Edward J. Holland, Michael L. Nordlund, et al.. (2004). Concentrations of Levofloxacin, Ofloxacin, and Ciprofloxacin in Human Corneal Stromal Tissue and Aqueous Humor After Topical Administration. Cornea. 23(3). 255–263. 45 indexed citations
14.
Healy, Daniel P., et al.. (2002). Effect of Antibiotics on Polymorphonuclear Neutrophil Apoptosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(5). 578–585. 12 indexed citations
15.
Healy, Daniel P., et al.. (1997). Reduced Tetracycline Bioavailability Caused by Magnesium Aluminum Silicate in Liquid Formulations of Bismuth Subsalicylate. Annals of Pharmacotherapy. 31(12). 1460–1464. 13 indexed citations
16.
Healy, Daniel P., et al.. (1996). Influence of drug class and dose size on antibiotic-induced endotoxin/IL-6 release and impact on efficacy of anti-endotoxin antibody. Journal of Endotoxin Research. 3(3). 219–227. 8 indexed citations
17.
Rossi, Stephen J., et al.. (1993). High-Dose Ciprofloxacin in the Treatment of a Renal Cyst Infection. Annals of Pharmacotherapy. 27(1). 38–39. 4 indexed citations
18.
Healy, Daniel P., et al.. (1992). In Vitro Delivery of Crushed Ciprofloxacin through a Feeding Tube. Annals of Pharmacotherapy. 26(4). 494–495. 3 indexed citations
19.
Sahai, Jan, et al.. (1989). Influence of Antihistamine Pretreatment on Vancomycin-Induced Red-Man Syndrome. The Journal of Infectious Diseases. 160(5). 876–881. 54 indexed citations
20.
Polk, Ronald E., et al.. (1988). Vancomycin and the Red-Man Syndrome: Pharmacodynamics of Histamine Release. The Journal of Infectious Diseases. 157(3). 502–507. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026